Dapagliflozin and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial

被引：0

作者：

Ostrominski, John ^{[1
]}

Vaduganathan, M. ^{[1
]}

Selvaraj, S. ^{[2
]}

Claggett, B. ^{[1
]}

Desai, A. ^{[1
]}

Jhund, P. ^{[3
]}

Kosiborod, M. ^{[4
]}

Lam, C. ^{[5
]}

Inzucchi, S. ^{[6
]}

Martinez, F. ^{[7
]}

De Boer, R. ^{[8
]}

Hernandez, A. ^{[9
]}

Shah, S. ^{[10
]}

Mcmurray, J. ^{[3
]}

Solomon, S. ^{[1
]}

机构：

[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA

[2] Duke Univ, Med Ctr, Durham, NC 27706 USA

[3] Univ Glasgow, Glasgow, Lanark, Scotland

[4] St Lukes Mid Amer Heart Inst, Kansas City, MO USA

[5] Natl Heart Ctr Singapore, Singapore, Singapore

[6] Yale Sch Med, New Haven, CT USA

[7] Univ Nacl Cordoba, Cordoba, Argentina

[8] Univ Med Ctr Groningen, Groningen, Netherlands

[9] Duke Clin Res Inst, Durham, NC USA

[10] Northwestern Mem Hosp, Chicago, IL 60611 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：41 / 41

页数：1